Press Releases about Moderna Inc
Exposures
COVID-19
From Moderna, Inc.
Via Business Wire
Moderna to Invest in New Science Center in Cambridge, MA
September 30, 2021
From Moderna, Inc.
Via Business Wire
Why Some Experts Say for an Effective COVID Vaccine, Look Beyond Antibodies to T-Cells
September 28, 2021
Exposures
COVID-19
From Moderna, Inc.
Via Business Wire
Moderna Announces Supply Agreement with Peru for 20 Million Doses of Its COVID-19 Vaccine
September 24, 2021
From Moderna, Inc.
Via Business Wire
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots
September 17, 2021
Exposures
COVID-19
Moderna Announces Health Canada Approves its COVID-19 Vaccine
September 16, 2021
From Moderna, Inc.
Via Business Wire
Moderna Highlights New Clinical Data on its COVID-19 Vaccine
September 15, 2021
From Moderna, Inc.
Via Business Wire
Moderna Announces Significant Advances Across Industry-Leading mRNA Portfolio at 2021 R&D Day
September 09, 2021
From Moderna, Inc.
Via Business Wire
Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
September 08, 2021
From Moderna, Inc.
Via Business Wire
Moderna to Present at Upcoming Investor Conferences in September 2021
September 02, 2021
From Moderna, Inc.
Via Business Wire
Moderna Announces Submission of Initial Data to U.S. FDA for Its COVID-19 Vaccine Booster
September 01, 2021
From Moderna, Inc.
Via Business Wire
Moderna to Host Virtual R&D Day on Thursday, September 9, 2021
August 24, 2021
From Moderna, Inc.
Via Business Wire
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.